Who owns the TOBRA-VANC trademark?

The TOBRA-VANC trademark is owned by Harrow IP, LLC.

What class is the TOBRA-VANC trademark registered in?

The TOBRA-VANC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for TOBRA-VANC?

The USPTO serial number for TOBRA-VANC is 97800304.

What is the registration number for TOBRA-VANC?

TOBRA-VANC is registered under USPTO registration number 7615274.

Sealvo

Home Search: TOBRA-VANCTOBRA-VANC #97800304

Back

Updated Oct 2, 2026·14 searches this week

View on USPTO TSDR Find similar marks

TOB

USPTO Trademark Record

REGISTERED

TOBRA-VANC

SN 97800304·Reg 7615274·Filed Feb 17, 2023

Owner Harrow IP, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

TOBRA-VANC (Serial No. 97800304), Registration No. 7615274, is a registered US trademark filed on Feb 17, 2023 by Harrow IP, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: December 17, 2030

Conflict Analysis

Full conflict analysis for TOBRA-VANC (SN 97800304) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

TOBRA-VANC (Reg. #7615274) is a registered US trademark that has been protecting its owner, Harrow IP, LLC, since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 17, 2023

SERIAL

97800304

REG#

7615274

REGISTERED

Dec 17, 2024

Filing Information

StatusREGISTERED

Filing DateFeb 17, 2023

Serial Number97800304

Registration No.7615274

Registration DateDec 17, 2024

Status DateOct 06, 2025

Published for OppositionDec 19, 2023

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1739382

480Jun 12, 2023

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 30, 2022

First use in commerce: Nov 30, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

18 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Oct 29, 2025

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

CANCELLATION INSTITUTED NO. 999999

Oct 06, 2025

CANCELLATION INSTITUTED NO. 999999

REGISTERED-PRINCIPAL REGISTER

Dec 17, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 17, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 17, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 17, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 16, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Oct 15, 2024

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Aug 12, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Aug 12, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 13, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 19, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 19, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 29, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 15, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 03, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 23, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 21, 2023

NEW APPLICATION ENTERED

Other Marks by Harrow IP, LLC

Additional USPTO filings from the same owner.

NAT

NATACYN (NATAMYCIN OPHTHALMIC SUSPENSION) 5%

98402032

Harrow IP, LLC

REGISTERED

LES

LESSDROPS

86497791

HARROW IP, LLC

REGISTERED

KLA

KLARITY-C

88180062

HARROW IP, LLC

REGISTERED

KLA

KLARITY-A

88180045

HARROW IP, LLC

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

FOR

FORTI-VANC

98619875

Harrow IP, LLC

PENDING

TRI

TRI-MOXI-VANC

87335606

IMPRIMIS PHARMACEUTICALS, INC.

ABANDONED

Other Marks by LAILA S. WOLFGRAM

Additional USPTO filings handled by the same attorney of record.

DDN

98402447

REGISTERED

PER

PERFSAVER

88320514

REGISTERED

CUB

CUBICASA TOUR

98719287

REGISTERED

LOG

LogoMark

88398910

REGISTERED

TOBRA-VANC

Run a conflict check

Other Marks by Harrow IP, LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by LAILA S. WOLFGRAM

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company